Chapter

Device therapy: which devices and for whom?

Roy S. Gardner, Theresa A. McDonagh and Niki L. Walker

in Heart Failure

Second edition

Published on behalf of Oxford University Press

Published in print August 2014 | ISBN: 9780199674152
Published online August 2014 | e-ISBN: 9780191781803 | DOI: https://dx.doi.org/10.1093/med/9780199674152.003.0006

Series: Oxford Specialist Handbooks in Cardiology

Device therapy: which devices and for whom?

Show Summary Details

Preview

The majority of patients with heart failure stabilize or improve with pharmacological therapy. Device therapy in heart failure addresses two potential consequences of left ventricular dysfunction, namely malignant ventricular arrhythmias that can lead to sudden cardiac death (SCD), and ventricular dyssynchrony. These two phenomena can coexist in the CHF patient. Cardiac resynchronization therapy (CRT) has a clear role in selected patients with advanced heart failure who remain symptomatic despite maximum tolerated pharmacological therapy. Implantable cardiac defibrillators (ICD) have also been shown to reduce arrhythmic deaths in both ischaemic and non-ischaemic cardiomyopathy. CRT can be combined with ICD functions (Cardiac Resynchronization Therapy-Defibrillator: CRT-D) to achieve the benefits of both devices. This chapter presents the evidence for the use of these devices, and summarizes the latest recommendations for the clinical guidelines.

Chapter.  6148 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.